New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 5, 2018 - Oceanside Pharmaceuticals launched an authorized generic version of Valeant Pharmaceuticals’ Clindagel (clindamycin phosphate) 1% topical gel.
Download PDF
Return to publications
